The GMC stresses that doctors must consider the limitations of electronic communication phone, internet, Skype etc when consulting remotely. Patients should also be made aware of the limitations of a remote consultation and have given their consent to continue. Injectable cosmetic treatments must not be prescribed remotely. Remote prescribing for patients overseas may be in breach of ethical and legal obligations if you are only registered to provide medical care in the UK.
Any guidance is intended as general guidance for members only. If you are a member and need specific advice relating to your own circumstances, please contact one of our advisers.
Some patients may have questions about licensed medications and driving. A known asthmatic declined steroid treatment in pregnancy, resulting in a very severe asthmatic episode. Despite bedside treatment from her GP, ambulance delays meant that hypoxic brain damage could not be prevented.
A practice with 10, patients may issue as many as 25, repeat prescriptions each year. A routine and repetitive task, it is one in which mistakes can easily be made and from which a significant percentage of MDU claims arise.
Home Guidance and advice Prescribing. Prescribing 5 January Prescription errors are one of the most common subjects for a claim notified to the MDU. Select an appropriate medication. Provide patients with information, warnings, and instructions.
Monitor the patient regularly. Consider drug costs when prescribing. Use appropriate tools, such as prescribing software and electronic drug references, to reduce prescription errors. Prescribing animal-derived medications Animal-derived ingredients such as lactose and gelatin are commonly used in prescription drugs. Managing prescription errors When faced with the choice between disclosing a prescription error and not disclosing, clinicians should always choose the former.
Tollison said to prevent future errors, clinicians should ask themselves several questions before prescribing any medication: Is this drug needed to treat the presenting problem? Is this the best drug for the problem? Are there any contraindications to this drug with this patient? Is the dosage correct? Does the patient have allergies or sensitivities to the drug? Is there a problem with the storage of the drug? Is the route of administration the most appropriate one? Is the proposed duration of treatment too short or too long?
Prescribing pain medication In states where FNPs have prescriptive authority, many are also legally authorized to prescribe controlled substances, including opioid painkillers.
The Nurse Practitioner Healthcare Foundation said clinical chronic care pain management requires four elements: A comprehensive assessment of the pain and past efforts to treat pain An examination of a wide range of treatment options besides opioids Ongoing patient education about the associated risks Vigilant follow up to mitigate possible substance abuse FNP Nursing and Medication Safety Medical professionals from the Nurse Practitioner Healthcare Foundation also said FNPs are in a position to align practice, policy, and research to optimize pain treatments while minimizing the risk for opioid abuse.
Get Program Details. This will only take a moment. What is your highest level of education? Do you currently hold an RN license? Please select an option Yes No Currently Obtaining. Until this is addressed, polypharmacy will remain problematic.
This blog is also featured on the Health Service Journal website. Related content. Report Polypharmacy and medicines optimisation: Making it safe and sound Our report looks at the occurrence of polypharmacy - the concurrent use of multiple medications by one individual - in primary and secondary care and in care homes, and offers recommendations for improving the current system. GPs and Patients need help coordinating treatment for multiple medical problems and pharmacists are ideally placed to provide the professional advice, guidance and practical support that patients need.
Whether the treatment was initiated in hospital or not, it is the responsibility of the prescriber to ensure that the prescribed medicine is indicated and that patients are responding well or the anticipated goals of treatment wont be realised and patients will be exposed to all the risk and none of the benefits. The 'medication review' currently in the GMS is clearly insufficient as it tends to continue with treatment without strong justification.
Pharmacists can monitor patient's treatment, especially in the early stages, to ensure that there is a good response and can address concerns patients may have with appropriate reassurance about minor side effects and prompt a GP led treatment review if major side effects begin to occur. Reply Link to comment. Care to provide a reference for this comment, John? And whilst your at at positive proof that "complementary therapy never killed anybody", or was associated with an opportunity cost?
Regulated systems have to provide a proof of concept, and cannot make spurious claims in this way. Having argued the case for evidence-basedpharmaeutical nteventions for years, I find the way in which unsubstantiated claims can be bandied about without accountability or repercussion quite perplexing.
As an elderly patient with LTCs and comorbidities, I could add my own sorry tales of harmful non communication between primary and secondary care to Duncan Hockey's excellent blog. A new development though now enables patients to keep track of the drugs which have been prescribed "here and there" and to manage all their regular and occasional medicine intakes. The bottom line is that prescribed drugs have become the third or fourth biggest killer, yet they are supposed to cure not kill, and doctors who prescribe them swear the Hippocratic oath to do no harm.
Complementary therapy never killed anybody, so the remedy is medication to meditation the active ingredient in complementary therapy The Mindfulness Based Cognitive Therapy 8 week courses is NICE recommended, so patients have the statutory right to it if their doctor says it is clinically appropriate.
As one in three patients in primary care present with anxiety or depression, commissioners should commission more courses by opening up the market.
0コメント